What Moderna said
- “I want to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.,” Bancel said.
Moderna is currently undergoing trials of a third shot, which the company announced earlier in 2021 as COVID-19 variants began to spread. Bancel said Moderna hopes to submit its trial data to the Food and Drug Administration — which would then give emergency approval for the vaccine booster — by the fall.
- “Our goal is to work really hard to get this ready before the fall,” Bancel told CNBC.
More on Moderna’s third shot
The current two-shot plan “generates a weaker immune response against the strain from South Africa, though the company said antibodies in patients remain above levels that are expected to be protective against the virus,” according to CNBC.
Dr. Fauci talks about third shots
Dr. Anthony Fauci, one of the United States’ top infectious disease experts, recently told MSNBC’s Mehdi Hasan that a third shot for two-dose COVID-19 vaccines might be necessary. But health officials need to monitor health trends for those who received the two doses to see when the third shot is necessary to keep immunity.
- “So the good news is that it’s at least six months,” Fauci said. “Hopefully a lot more. But in direct answer to your question, if it turns out a year or a year and a half, we very well may need to get booster shots to keep up the level of protection.”